Vertex Pharmaceuticals Inc (VRTX)
400.73
-3.88
(-0.96%)
USD |
NASDAQ |
Apr 24, 16:00
400.73
0.00 (0.00%)
After-Hours: 16:07
Vertex Pharmaceuticals Cash from Investing (TTM): -3.142B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.142B |
| September 30, 2023 | -2.080B |
| June 30, 2023 | -2.346B |
| March 31, 2023 | -2.104B |
| December 31, 2022 | -321.10M |
| September 30, 2022 | -630.70M |
| June 30, 2022 | -299.40M |
| March 31, 2022 | -317.60M |
| December 31, 2021 | -340.90M |
| September 30, 2021 | 36.86M |
| June 30, 2021 | -158.18M |
| March 31, 2021 | -6.566M |
| December 31, 2020 | 99.40M |
| September 30, 2020 | -1.041B |
| June 30, 2020 | -1.042B |
| March 31, 2020 | -1.164B |
| December 31, 2019 | -1.235B |
| September 30, 2019 | -379.23M |
| June 30, 2019 | -180.12M |
| March 31, 2019 | -246.23M |
| December 31, 2018 | -202.16M |
| September 30, 2018 | -182.04M |
| June 30, 2018 | -357.43M |
| March 31, 2018 | -317.42M |
| December 31, 2017 | -483.33M |
| Date | Value |
|---|---|
| September 30, 2017 | -285.61M |
| June 30, 2017 | -25.53M |
| March 31, 2017 | -7.033M |
| December 31, 2016 | 51.24M |
| September 30, 2016 | -248.39M |
| June 30, 2016 | -384.12M |
| March 31, 2016 | -47.89M |
| December 31, 2015 | 268.86M |
| September 30, 2015 | 373.54M |
| June 30, 2015 | 505.02M |
| March 31, 2015 | 316.45M |
| December 31, 2014 | 82.01M |
| September 30, 2014 | -19.79M |
| June 30, 2014 | -0.799M |
| March 31, 2014 | -95.37M |
| December 31, 2013 | -112.56M |
| September 30, 2013 | 14.40M |
| June 30, 2013 | -166.36M |
| March 31, 2013 | -231.71M |
| December 31, 2012 | -425.82M |
| September 30, 2012 | -820.75M |
| June 30, 2012 | -668.08M |
| March 31, 2012 | -425.24M |
| December 31, 2011 | 212.41M |
| September 30, 2011 | 430.49M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-3.142B
Minimum
Dec 2023
99.40M
Maximum
Dec 2020
-876.43M
Average
-379.23M
Median
Sep 2019
Cash from Investing (TTM) Benchmarks
| Amgen Inc | -26.20B |
| Eli Lilly and Co | -7.153B |
| Regeneron Pharmaceuticals Inc | -3.185B |
| Alpine Immune Sciences Inc | -55.56M |
| Moderna Inc | 4.206B |